How Drug Companies Use AI Monitoring to Protect Brand, Safety, and Market Share
In 2023, a patient in a Reddit thread described asking ChatGPT about Ozempic dosing. The AI told her it was […]
General
Which Drug Categories AI Hallucinates Most — and What Pharma Must Do Now
In March 2024, a cardiologist in Houston noticed something odd. A patient arrived at their appointment quoting drug interaction warnings
LLMs vs. Pharma Websites: Which Explains Drug Side Effects Better — And What It Costs Brands
Ask the official Humira website what side effects patients should expect. You will get a dense PDF, a legal disclaimer,
AI Is Rewriting Your Drug Label — Without Asking
Every day, tens of millions of patients and physicians type drug questions into ChatGPT, Gemini, Claude, and Perplexity. They get
AI Became Your Patient’s Drug Counselor. Pharma Didn’t Get a Vote.
Somewhere between the formulary decision and the first filled prescription, a patient opens ChatGPT and asks: “Is Ozempic safe for
The Pharma AI Visibility Problem: Why Your Drug Is Losing Ground in ChatGPT, Gemini, and Claude — And What to Do About It
Six months ago, a brand director at a mid-sized specialty pharma company asked ChatGPT what the leading treatment options were
How to Benchmark AI Responses Against FDA Labels: A Pharma Brand Team’s Playbook
When a physician types “what is the maximum dose of Jardiance in heart failure” into ChatGPT, the answer that comes
AI Models Are Training on Old Drug Information. Here’s the Risk.
In March 2023, FDA updated the labeling for tofacitinib (Xeljanz) to strengthen a boxed warning about serious cardiac events, malignancy,
Pharma SEO Is Dead. AI Answers Killed It. Here’s What Replaces It.
A physician types “best GLP-1 for weight loss” into ChatGPT. A patient asks Claude which SGLT2 inhibitor has the fewest
How Drug Companies Use AI Monitoring to Protect Brand, Safety, and Market Share
In 2023, a patient in a Reddit thread described asking ChatGPT about Ozempic dosing. The AI told her it was
The Drug Intelligence Gold Mine Pharma Isn’t Mining: AI Conversations at Scale
Every pharmaceutical company has a market research budget. They commission syndicated studies, run physician surveys, pay IQVIA for prescribing data,
Off-Label Drift: How AI Pushes Drugs Beyond Their Approved Indications — And What Pharma Must Do About It
Nobody at Novo Nordisk promoted Ozempic for fatty liver disease. Nobody had to. Ask ChatGPT whether semaglutide helps with metabolic-associated